147 related articles for article (PubMed ID: 37708128)
21. Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.
Penazzato M; Prendergast AJ; Muhe LM; Tindyebwa D; Abrams E
Cochrane Database Syst Rev; 2014 May; 2014(5):CD004772. PubMed ID: 24852077
[TBL] [Abstract][Full Text] [Related]
22. Ten years of antiretroviral therapy: Incidences, patterns and risk factors of opportunistic infections in an urban Ugandan cohort.
Weissberg D; Mubiru F; Kambugu A; Fehr J; Kiragga A; von Braun A; Baumann A; Kaelin M; Sekaggya-Wiltshire C; Kamya M; Castelnuovo B
PLoS One; 2018; 13(11):e0206796. PubMed ID: 30383836
[TBL] [Abstract][Full Text] [Related]
23. Prevalence, incidence, predictors, treatment, and control of hypertension among HIV-positive adults on antiretroviral treatment in public sector treatment programs in South Africa.
Brennan AT; Jamieson L; Crowther NJ; Fox MP; George JA; Berry KM; Stokes A; Maskew M; Sanne I; Long L; Cassim N; Rosen S
PLoS One; 2018; 13(10):e0204020. PubMed ID: 30281618
[TBL] [Abstract][Full Text] [Related]
24. Retention in care of HIV-infected children from HIV test to start of antiretroviral therapy: systematic review.
Mugglin C; Wandeler G; Estill J; Egger M; Bender N; Davies MA; Keiser O
PLoS One; 2013; 8(2):e56446. PubMed ID: 23437135
[TBL] [Abstract][Full Text] [Related]
25. Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.
Lodi S; Phillips A; Logan R; Olson A; Costagliola D; Abgrall S; van Sighem A; Reiss P; Miró JM; Ferrer E; Justice A; Gandhi N; Bucher HC; Furrer H; Moreno S; Monge S; Touloumi G; Pantazis N; Sterne J; Young JG; Meyer L; Seng R; Dabis F; Vandehende MA; Pérez-Hoyos S; Jarrín I; Jose S; Sabin C; Hernán MA;
Lancet HIV; 2015 Aug; 2(8):e335-43. PubMed ID: 26423376
[TBL] [Abstract][Full Text] [Related]
26. Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapy.
Jose S; Quinn K; Hill T; Leen C; Walsh J; Hay P; Fisher M; Post F; Nelson M; Gompels M; Johnson M; Chadwick D; Gilson R; Sabin C; Fidler S;
AIDS; 2014 Jun; 28(9):1333-9. PubMed ID: 24583670
[TBL] [Abstract][Full Text] [Related]
27. Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration.
Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration
Lancet HIV; 2019 Feb; 6(2):e105-e115. PubMed ID: 30723008
[TBL] [Abstract][Full Text] [Related]
28. Characteristics, mortality and outcomes at transition for adolescents with perinatal HIV infection in Asia.
Bartlett AW; Truong KH; Songtaweesin WN; Chokephaibulkit K; Hansudewechakul R; Ly PS; Lumbiganon P; Sudjaritruk T; Nguyen LV; Do VC; Kumarasamy N; Nik Yusoff NK; Kurniati N; Fong MS; Wati DK; Nallusamy R; Sohn AH; Law MG; Mohamed TJ
AIDS; 2018 Jul; 32(12):1689-1697. PubMed ID: 29794827
[TBL] [Abstract][Full Text] [Related]
29. Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia.
Boettiger DC; Sudjaritruk T; Nallusamy R; Lumbiganon P; Rungmaitree S; Hansudewechakul R; Kumarasamy N; Bunupuradah T; Saphonn V; Truong KH; Yusoff NKN; Do VC; Nguyen LV; Razali KAM; Fong SM; Kurniati N; Kariminia A
J Adolesc Health; 2016 Apr; 58(4):451-459. PubMed ID: 26803201
[TBL] [Abstract][Full Text] [Related]
30. Association between age at antiretroviral therapy initiation and 24-month immune response in West-African HIV-infected children.
Desmonde S; Dicko F; Koueta F; Eboua T; Balestre E; Amani-Bosse C; Aka EA; Lawson-Evi K; Amorissani-Folquet M; Kouakou K; Koumakpai S; Renner L; Signaté Sy H; Leroy V;
AIDS; 2014 Jul; 28(11):1645-55. PubMed ID: 24804858
[TBL] [Abstract][Full Text] [Related]
31. Sex Differences in Antiretroviral Therapy Initiation in Pediatric HIV Infection.
Mori M; Adland E; Paioni P; Swordy A; Mori L; Laker L; Muenchhoff M; Matthews PC; Tudor-Williams G; Lavandier N; van Zyl A; Hurst J; Walker BD; Ndung'u T; Prendergast A; Goulder P; Jooste P
PLoS One; 2015; 10(7):e0131591. PubMed ID: 26151555
[TBL] [Abstract][Full Text] [Related]
32. Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART)] study in South Africa.
Bock P; Nel K; Fatti G; Sloot R; Ford N; Voget J; Gunst C; Grobbelaar N; Louis F; Floyd S; Hayes R; Ayles H; Beyers N; Fidler S;
HIV Med; 2019 Jul; 20(6):392-403. PubMed ID: 30963667
[TBL] [Abstract][Full Text] [Related]
33. Incidence of Opportunistic Infections and the Impact of Antiretroviral Therapy Among HIV-Infected Adults in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.
Low A; Gavriilidis G; Larke N; B-Lajoie MR; Drouin O; Stover J; Muhe L; Easterbrook P
Clin Infect Dis; 2016 Jun; 62(12):1595-1603. PubMed ID: 26951573
[TBL] [Abstract][Full Text] [Related]
34. Incidence and Predicting Factors of Opportunistic Infections after Antiretroviral Therapy Initiation among Treatment-naïve Patients with HIV Infection: A Retrospective Cohort Study in A Tertiary Care Hospital.
Wongkittipong P; Kiertiburanakul S
J Int Assoc Provid AIDS Care; 2024; 23():23259582241241167. PubMed ID: 38592111
[TBL] [Abstract][Full Text] [Related]
35. CD4+ cell count recovery following initiation of HIV antiretroviral therapy in older childhood and adolescence.
Simms V; Rylance S; Bandason T; Dauya E; McHugh G; Munyati S; Mujuru H; Rowland-Jones SL; Weiss HA; Ferrand RA
AIDS; 2018 Sep; 32(14):1977-1982. PubMed ID: 29927784
[TBL] [Abstract][Full Text] [Related]
36. Brief Report: AIDS-Defining Events and Deaths in HIV-Infected Children and Adolescents on Antiretrovirals: A 14-Year Study in Thailand.
Traisathit P; Delory T; Ngo-Giang-Huong N; Somsamai R; Techakunakorn P; Theansavettrakul S; Kanjanavanit S; Mekmullica J; Ngampiyaskul C; Na-Rajsima S; Lallemant M; Cressey TR; Jourdain G; Collins IJ; Le Coeur S
J Acquir Immune Defic Syndr; 2018 Jan; 77(1):17-22. PubMed ID: 29040162
[TBL] [Abstract][Full Text] [Related]
37. Temporal Trends in Patient Characteristics and Outcomes Among Children Enrolled in Mozambique's National Antiretroviral Therapy Program.
Auld AF; Alfredo C; Macassa E; Jobarteh K; Shiraishi RW; Rivadeneira ED; Houston J; Spira TJ; Ellerbrock TV; Vaz P
Pediatr Infect Dis J; 2015 Aug; 34(8):e191-9. PubMed ID: 25955836
[TBL] [Abstract][Full Text] [Related]
38. The shift in tuberculosis timing among people living with HIV in the course of antiretroviral therapy scale-up in Malawi.
Tweya H; Feldacker C; Mpunga J; Kanyerere H; Heller T; Ganesh P; Nkosi D; Kalulu M; Sinkala G; Satumba T; Phiri S
J Int AIDS Soc; 2019 Apr; 22(4):e25240. PubMed ID: 31038836
[TBL] [Abstract][Full Text] [Related]
39. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
Desmonde S; Tanser F; Vreeman R; Takassi E; Edmonds A; Lumbiganon P; Pinto J; Malateste K; McGowan C; Kariminia A; Yotebieng M; Dicko F; Yiannoutsos C; Mubiana-Mbewe M; Wools-Kaloustian K; Davies MA; Leroy V;
PLoS Med; 2018 May; 15(5):e1002565. PubMed ID: 29727458
[TBL] [Abstract][Full Text] [Related]
40. Characteristics and outcomes of HIV-infected youth and young adolescents enrolled in HIV care in Kenya.
Koech E; Teasdale CA; Wang C; Fayorsey R; Alwar T; Mukui IN; Hawken M; Abrams EJ
AIDS; 2014 Nov; 28(18):2729-38. PubMed ID: 25493599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
